pISSN 2508-6235 eISSN 2508-7576

Table. 1.

Baseline characteristics of the subjects

Variable Total (n=61) G1 (n=24) G2 (n=12) G3 (n=25) P
Age (yr) 58.5±9.6 59.9±10.4 57.1±12.0 57.8±7.5 0.652
Male sex (%) 32 (52.5) 12 (50) 7 (58) 12 (48) 0.893
Duration of DM (yr) 11.4±5.6 8.2±4.0 13.3±5.1 13.6±5.8 0.001*
Weight (kg) 72.6±12.1 72.6±12.1 73.5±13.4 72.0±11.9 0.938
Height (m) 1.63±0.08 1.61±0.07 1.65±0.08 1.63±0.09 0.513
BMI (kg/m2) 27.3±3.6 27.8±3.7 26.9±3.6 27.0±3.7 0.690
SBP (mmHg) 132.1±11.6 132.5±10.7 132.3±19.3 131.6±7.6 0.968
DBP (mmHg) 80.2±7.7 80.7±7..0 81.8±9.3 79.0±7.8 0.562
HbA1c (%) 7.6±1.0 6.87±0.80 7.75±1.04 8.17±0.73 <0.001
PP2 (mg/dL) 194.2±69.8 162.5±43.1 223.7±111.2  210.4±54.8  0.012*
Fasting plasma glucose (mg/dL) 163.8±60.3 149.3±48.3  168.3±85.2  173.5±54.8 0.265
Total cholesterol (mg/dL) 144.4±31.3 140.4±33.6 151.3±36.8 144.9±36.8 0.624
Triglycerides (mg/dL) 138.3±69.5 136.8±63.4 124.9±77.6 146.2±72.9 0.686
HDL-C (mg/dL) 48.9±11.2 49.3±12.9 48.6±8.6 48.7±10.8 0.978
LCL-C (mg/dL) 77.2±26.5 74.1±30.0 85.8±28.7 76.0±21.7 0.452
BUN (mg/dL) 16.3±5.6 16.0±4.6 16.6±4.8 16.5±6.8 0.949
Cr (mg/dL) 0.86±0.22 0.85±0.19 0.82±0.24 0.89±0.23 0.604
eGFR (mL/min) 87.2±18.6 86.9±16.8 91.8±21.5 85.4±19.1 0.622
BUN (mg/dL, 12 mo later) 17.1±4.7 17.3±5.1 18.3±4.3 16.4±4.4 0.424
Cr (mg/dL, 12 mo later) 0.82±0.21 0.81±0.18 0.81±0.24 0.84±0.22 0.763
eGFR (mL/min, 12 mo later) 89.5±16.8 89.1±14.0 93.3±20.1 88.0±18.0 0.747

Values are presented as mean±standard deviation or number (%).

P<0.05.

G, group; yr, year; DM, diabetes mellitus; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; PP2, post prandial plasma glucose 2 hours; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimated glomerular filtration rate.

J Obes Metab Syndr 2017;26:107~113 https://doi.org/10.7570/jomes.2017.26.2.107
© JOMES